The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (Hepatitis B/C, HIV): A review of the available evidence

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
The safety and efficacy of immune checkpoint inhibitors in patients with advanced cancers and pre-existing chronic viral infections (Hepatitis B/C, HIV): A review of the available evidence
Authors
Keywords
Immunotherapy, Checkpoint inhibitor, PD-1, PD-L1, CTLA-4, Chronic viral infection, Hepatitis B, Hepatitis C, Reactivation, HIV, Cancer
Journal
CANCER TREATMENT REVIEWS
Volume 86, Issue -, Pages 102011
Publisher
Elsevier BV
Online
2020-03-18
DOI
10.1016/j.ctrv.2020.102011

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.